Emergent BioSolutions to Participate in Investor Conferences
Emergent BioSolutions (NYSE: EBS) announced participation in upcoming investor conferences.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
Emergent BioSolutions (NYSE: EBS) announced participation in upcoming investor conferences. The company will hold 1-on-1 meetings at the Goldman Sachs Credit and Leveraged Finance Conference on May 17, 2021, and at the Benchmark Company Healthcare House Call Conference on May 26, 2021. Additionally, a company presentation is scheduled during the Singular Research Spring Select Webcall on May 27, 2021, at 8:00 am Pacific / 11:00 am Eastern. Webcast presentations will discuss recent business developments and financial results, accessible live and via replay on the Emergent website.
Details
News Market Reaction – EBS
The recorded move for EBS in the trading session of this news was -0.26%.
Data tracked by StockTitan Argus. Session date unavailable.
AI-generated analysis. How Rhea-AI works. Not financial advice.
GAITHERSBURG, Md., May 05, 2021 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE: EBS) announced today that members of the company’s senior management team will participate in the following investor conferences:
- Goldman Sachs Credit and Leveraged Finance Conference
May 17, 2021
1-on-1 meetings only
- Benchmark Company Healthcare House Call Conference
May 26, 2021
1-on-1 meetings only
- Singular Research Spring Select Webcall
May 27, 2021
Company presentation scheduled at 8:00 am Pacific / 11:00 am Eastern
For conferences where a presentation is planned, the company’s webcast presentation may include a discussion of the company's recent business developments as well as its financial results and guidance. The webcast will be available both live, if possible, and by replay, and will be accessible from the Emergent website.
About Emergent BioSolutions
Emergent BioSolutions is a global life sciences company whose mission is to protect and enhance life. Through our specialty products and contract development and manufacturing services, we are dedicated to providing solutions that address public health threats. Through social responsibility, we aim to build healthier and safer communities. We aspire to deliver peace of mind to our patients and customers so they can focus on what’s most important in their lives. In working together, we envision protecting or enhancing 1 billion lives by 2030. For more information, visit our website and follow us on LinkedIn, Twitter, and Instagram.
Investor Contact:
Robert G. Burrows
Vice President, Investor Relations
240-631-3280
burrowsr@ebsi.com
Media Contact:
Matt Hartwig
Director, Media Relations
hartwigm@ebsi.com
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.